Analysis of Ah receptor pathway activation by brominated flame retardants.

Brominated flame-retardants (BFRs) are used as additives in plastics to decrease the rate of combustion of these materials, leading to greater consumer safety. As the use of plastics has increased, the production and use of flame-retardants has also grown. Many BFRs are persistent and have been detected in environmental samples, raising concerns about the biological/toxicological risk associated with their use. Most BFRs appear to be non-toxic, however there is still some concern that these compounds, or possible contaminants in BFRs mixtures could interact with cellular receptors. In this study we have examined the interaction of decabromodiphenyl ether, Firemaster BP4A (tetrabromobisphenol A), Firemaster PHT4 (tetrabromophthalic anhydride), hexabromobenzene, pentabromotoluene, decabromobiphenyl, Firemaster BP-6 (2,2',4,4',5,5'-hexabromobiphenyl) and possible contaminants of BFR mixtures with the Ah receptor. Receptor binding and activation was examined using the Gel Retardation Assay and increased expression of dioxin responsive genes was detected using the reporter gene based CALUX assay. The results demonstrate the ability of BFRs to activate the AhR signal transduction pathway at moderate to high concentrations as assessed using both assays. AhR-dependent activation by BFRs may be due in part to contaminants present in commercial/technical mixtures. This was suggested by our comparative analysis of Firemaster BP-6 versus its primary component 2,2',4,4',5,5'-hexabromobiphenyl. Some technical mixtures of brominated flame-retardants contain brominated biphenyls, dioxins or dibenzofurans as contaminants. When tested in the CALUX assay these compounds were found to be equivalent to, or more active than their chlorinated analogues. Relative effective potency values were determined from dose response curves for these brominated HAHs.

[1]  I. Meerts,et al.  Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  H. Kay.  Environmental Health Criteria , 1980 .

[3]  S. Safe,et al.  Immunosuppressive and monooxygenase induction activities of highly chlorinated diphenyl ether congeners in C57BL/6 and DBA/2 mice. , 1993, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[4]  S. Safe.  Polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs): biochemistry, toxicology, and mechanism of action. , 1984, Critical reviews in toxicology.

[5]  Åke Bergman,et al.  Brominated flame retardants in serum from us blood donors , 2000 .

[6]  S. Safe,et al.  Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. , 1994, Critical reviews in toxicology.

[7]  I. Meerts,et al.  In vitro estrogenicity of polybrominated diphenyl ethers, hydroxylated PDBEs, and polybrominated bisphenol A compounds. , 2001, Environmental health perspectives.

[8]  J. Giesy,et al.  Chemical-activated luciferase gene expression (CALUX): a novel in vitro bioassay for Ah receptor active compounds in sediments and pore water. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[9]  A Poland,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.

[10]  M. Romkes,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antioestrogens: characterization and mechanism of action. , 1991, Pharmacology & toxicology.

[11]  N. Bunce,et al.  Synthesis of polybrominated diphenyl ethers and their capacity to induce CYP1A by the Ah receptor mediated pathway. , 2001, Environmental science & technology.

[12]  K. Norén,et al.  Certain organochlorine and organobromine contaminants in Swedish human milk in perspective of past 20-30 years. , 2000, Chemosphere.

[13]  Safe,et al.  Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. , 1998, Environmental health perspectives.

[14]  J. Mennear,et al.  Polybrominated dibenzo-p-dioxins and dibenzofurans: literature review and health assessment. , 1994, Environmental health perspectives.

[15]  S. Safe,et al.  Polybrominated dibenzo-p-dioxins and related compounds: quantitative in vivo and in vitro structure-activity relationships. , 1987, Toxicology.

[16]  J. Giesy,et al.  Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[17]  K M Crofton,et al.  Effects of short-term in vivo exposure to polybrominated diphenyl ethers on thyroid hormones and hepatic enzyme activities in weanling rats. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  D. Lenoir,et al.  Thermal formation of polybrominated dibenzodioxins (PBDD) and dibenzofurans (PBDF) from bromine containing flame retardants , 1989 .

[19]  M. DeVito,et al.  Dose–Response Relationships for Polyhalogenated Dioxins and Dibenzofurans Following Subchronic Treatment in Mice , 1997 .

[20]  B. van der Burg,et al.  Interference between Progesterone and Dioxin Signal Transduction Pathways , 1998, The Journal of Biological Chemistry.

[21]  John P. Giesy,et al.  Derivation and application of relative potency estimates based on in vitro bioassay results , 2000 .

[22]  S. Seidel,et al.  Ah receptor-based chemical screening bioassays: application and limitations for the detection of Ah receptor agonists. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  C. A. Wit.  An overview of brominated flame retardants in the environment. , 2002 .

[24]  M E Andersen,et al.  A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: tissue distribution and CYP1A induction. , 1993, Toxicology and applied pharmacology.

[25]  G. Söderström,et al.  Pxdd and pxdf from combustion of bromoflameretardent containing MSW , 2000 .

[26]  K. Norén,et al.  Analysis of polybrominated diphenyl ethers in Swedish human milk. A time-related trend study, 1972-1997. , 1999, Journal of toxicology and environmental health. Part A.

[27]  J. V. Bonilla,et al.  Analyses of Brominated Dibenzo-P-Dioxins and Dibenzofurans in ABS Resins Containing Brominated Flame Retardants , 1990 .

[28]  M. Maines.  Current protocols in toxicology , 1999 .

[29]  H. Buser.  Brominated and brominated/chlorinated dibenzodioxins and dibenzofurans: potential environmental contaminants , 1987 .

[30]  E. Glover,et al.  Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. , 1976, The Journal of biological chemistry.

[31]  S. Safe,et al.  Polychlorinated diphenyl ethers—A review , 1991 .

[32]  S. Safe,et al.  Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). , 1990, Critical reviews in toxicology.

[33]  G. Clark,et al.  Trace contamination with dioxin-like chemicals: evaluation of bioassay-based TEQ determination for hazard assessment and regulatory responses , 2001 .

[34]  C. A. Wit,et al.  Polybrominated diphenyl ethers (PBDE) in biological samples from the Swedish environment , 1993 .

[35]  N. Kerkvliet,et al.  Immunologic and endocrine effects of the flame-retardant pentabromodiphenyl ether (DE-71) in C57BL/6J mice. , 1994, Toxicology.

[36]  M. Denison,et al.  Development and modification of a recombinant cell bioassay to directly detect halogenated and polycyclic aromatic hydrocarbons in serum. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  M W Hornung,et al.  Toxic equivalency factors of polybrominated dibenzo-p-dioxin, dibenzofuran, biphenyl, and polyhalogenated diphenyl ether congeners based on rainbow trout early life stage mortality. , 1996, Toxicology and applied pharmacology.

[38]  H Greim,et al.  The toxicity of brominated and mixed-halogenated dibenzo-p-dioxins and dibenzofurans: an overview. , 1997, Journal of toxicology and environmental health.

[39]  M. Denison,et al.  Analysis of the Aryl Hydrocarbon Receptor (AhR) Signal Transduction Pathway , 2002, Current protocols in toxicology.

[40]  C. Tohyama,et al.  Cross-talk between 2,3,7,8-tetrachlorodibenzo-p-dioxin and testosterone signal transduction pathways in LNCaP prostate cancer cells. , 1999, Biochemical and biophysical research communications.

[41]  F. Lin,et al.  The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah nonresponsive C57BL/6J mice. , 1991, Toxicology and Applied Pharmacology.

[42]  C. Richter,et al.  Production of a novel recombinant cell line for use as a bioassay system for detection of 2,3,7,8‐tetrachlorodibenzo‐P‐dioxin‐like chemicals , 1994 .

[43]  J. Giesy,et al.  Ethoxyresorufin‐O‐deethylase induction potency of polychlorinated diphenyl ethers in H4IIE rat hepatoma cells , 1996 .